Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis
Atherosclerosis is characterized by subendothelial lipid retention believed to be the result of endothelial trancytosis. Here, the authors show that endothelium can take up and process LDL, generating cholesterol crystals that are deposited on the ...
Yvonne Baumer+7 more
doaj +1 more source
Inhibition of Type 4 Phosphodiesterase by Rolipram and Ginkgo biloba Extract (EGb 761) Decreases Agonist-Induced Rises in Internal Calcium in Human Endothelial Cells [PDF]
Manuel Campos‐Toimil+3 more
openalex +1 more source
Background: Gastroprokinetic properties of 5-HT4 receptor agonists, such as prucalopride, are attributed to activation of 5-HT4 receptors on cholinergic nerves innervating smooth muscle in the gastrointestinal smooth muscle layer, increasing ...
Afzal+54 more
core +1 more source
Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor [PDF]
Takayoshi Mamiya+7 more
openalex +1 more source
Rolipram inhibits leukocyte‐endothelial cell interactions in vivo through P‐ and E‐selectin downregulation [PDF]
María‐Jesús Sanz+7 more
openalex +1 more source
Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro [PDF]
Forssmann, W. G.+6 more
core +1 more source
The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function [PDF]
Amanda J. Miller
openalex +1 more source
Development of a Catalytic Enantioselective Conjugate Addition of 1,3‐Dicarbonyl Compounds to Nitroalkenes for the Synthesis of Endothelin‐A Antagonist ABT‐546. Scope, Mechanism, and Further Application to the Synthesis of the Antidepressant Rolipram. [PDF]
David M. Barnes, NULL AUTHOR_ID
openalex +1 more source
Untargeted Metabolomic Profiling of Rolipram-Stimulated Immune Cells [PDF]
Inflammation is a significant component of neurological diseases such as multiple sclerosis (MS). One potential anti-inflammatory agent, rolipram, was tested for efficacy in MS; however, despite showing promise in early trials, the drug has been largely ...
Shriber, Sterling, II
core +1 more source